Covered recipient · General Payments record
LI JIANG
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$3,277.05
- Reported across 187 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $473.88 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $163.10 | 6 |
| Amgen Inc. | $134.96 | 10 |
| ANI Pharmaceuticals, Inc. | $42.74 | 2 |
| GlaxoSmithKline, LLC. | $39.07 | 2 |
| PFIZER INC. | $22.99 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.35 | 1 |
| E.R. Squibb & Sons, L.L.C. | $20.68 | 1 |
| Ultragenyx Pharmaceutical Inc. | $14.42 | 1 |
| Lilly USA, LLC | $13.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.07 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103996505 | CMS |
| ABBVIE INC. | $27.39 | 03/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103996507 | CMS |
| ABBVIE INC. | $30.32 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103996509 | CMS |
| ABBVIE INC. | $27.08 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103996511 | CMS |
| ABBVIE INC. | $29.75 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103996513 | CMS |
| ABBVIE INC. | $32.49 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103996515 | CMS |
| Amgen Inc. | $21.61 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609687 | CMS |
| Amgen Inc. | $2.33 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609689 | CMS |
| Amgen Inc. | $16.78 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609683 | CMS |
| Amgen Inc. | $11.76 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609681 | CMS |
| Amgen Inc. | $5.60 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609685 | CMS |
| Amgen Inc. | $4.03 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609691 | CMS |
| Amgen Inc. | $18.39 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609693 | CMS |
| Amgen Inc. | $18.94 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117287735 | CMS |
| Amgen Inc. | $8.37 | 09/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609695 | CMS |
| Amgen Inc. | $27.15 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111609697 | CMS |
| ANI Pharmaceuticals, Inc. | $20.87 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091160874 | CMS |
| ANI Pharmaceuticals, Inc. | $21.87 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091139398 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.35 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118128169 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.68 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101482151 | CMS |
| GlaxoSmithKline, LLC. | $22.01 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116419957 | CMS |
| GlaxoSmithKline, LLC. | $17.06 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116683303 | CMS |
| Lilly USA, LLC | $13.57 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135151858 | CMS |
| PFIZER INC. | $22.99 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131245459 | CMS |
| Ultragenyx Pharmaceutical Inc. | $14.42 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153289180 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.